Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

5-Aza-2'-deoxycytidine and interleukin-1 cooperate to regulate matrix metalloproteinase-3 gene expression.

Couillard J, Estève PO, Pradhan S, St-Pierre Y.

Int J Cancer. 2011 Nov 1;129(9):2083-92. doi: 10.1002/ijc.25865.

3.
4.

IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Chambers M, Kirkpatrick G, Evans M, Gorski G, Foster S, Borghaei RC.

Exp Cell Res. 2013 Jun 10;319(10):1398-408. doi: 10.1016/j.yexcr.2013.04.010.

5.

The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells.

Poplineau M, Schnekenburger M, Dufer J, Kosciarz A, Brassart-Pasco S, Antonicelli F, Diederich M, Trussardi-Régnier A.

Mol Carcinog. 2015 Jan;54(1):24-34. doi: 10.1002/mc.22071.

PMID:
24038389
6.

Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation.

Poplutz MK, Wessels I, Rink L, Uciechowski P.

Immunobiology. 2014 Aug;219(8):619-26. doi: 10.1016/j.imbio.2014.03.016.

PMID:
24746556
7.

Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.

Karpf AR, Lasek AW, Ririe TO, Hanks AN, Grossman D, Jones DA.

Mol Pharmacol. 2004 Jan;65(1):18-27.

8.

Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.

Raymond L, Eck S, Mollmark J, Hays E, Tomek I, Kantor S, Elliott S, Vincenti M.

J Cell Physiol. 2006 Jun;207(3):683-8.

PMID:
16453302
9.

DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes.

Hashimoto K, Oreffo RO, Gibson MB, Goldring MB, Roach HI.

Arthritis Rheum. 2009 Nov;60(11):3303-13. doi: 10.1002/art.24882.

10.

A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons.

Wang Y, Wang X, Li R, Yang ZF, Wang YZ, Gong XL, Wang XM.

CNS Neurosci Ther. 2013 Mar;19(3):183-90. doi: 10.1111/cns.12059.

PMID:
23441691
11.
12.

[Effects of 5-Aza-dC on 5-Fu chemosensitivity by modulating TIP30 gene expression in human colorectal cancer cells].

Chen XB, Chen BB, Li J, Wang XF, Ma YJ, Luo SX, Lü HF.

Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):824-7. Chinese.

PMID:
24447479
13.

Gene reactivation by 5-aza-2'-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions.

Yang X, Noushmehr H, Han H, Andreu-Vieyra C, Liang G, Jones PA.

PLoS Genet. 2012;8(3):e1002604. doi: 10.1371/journal.pgen.1002604.

14.

HSPC117 is regulated by epigenetic modification and is involved in the migration of JEG-3 cells.

Ma H, Qi MY, Zhang X, Zhang YL, Wang L, Li ZQ, Fu B, Wang WT, Liu D.

Int J Mol Sci. 2014 Jun 17;15(6):10936-49. doi: 10.3390/ijms150610936.

15.

Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.

Reu FJ, Bae SI, Cherkassky L, Leaman DW, Lindner D, Beaulieu N, MacLeod AR, Borden EC.

J Clin Oncol. 2006 Aug 10;24(23):3771-9.

PMID:
16801630
16.

Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.

Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP.

Invasion Metastasis. 1992;12(3-4):168-84.

PMID:
1284126
17.
18.

Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells.

Kim JG, Bae JH, Kim JA, Heo K, Yang K, Yi JM.

PLoS One. 2014 Aug 19;9(8):e105405. doi: 10.1371/journal.pone.0105405.

20.

5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.

Liu Z, Zhang L, Ding F, Li J, Guo M, Li W, Wang Y, Yu Z, Zhan Q, Wu M, Liu Z.

Cancer Lett. 2005 Dec 18;230(2):271-83.

PMID:
16297713
Items per page

Supplemental Content

Support Center